Qyuns Therapeutics Subscribes to Two Wealth Management Products from Shanghai Pudong Development Bank

MT Newswires Live07-22

Qyuns Therapeutics (HKG:2509) subscribed for 160 million yuan in two wealth management products from Shanghai Pudong Development Bank (SHA:600000), according to a Friday filing with the Hong Kong Stock Exchange.

The first product is worth 100 million yuan with a guaranteed yield of 1.2% and a floating mid-range yield of 0% or 1.1% or a 1.3% high-range floating yield.

The second product is worth 60 million yuan with a guaranteed yield of 1.2% and a floating mid-range yield of 0% or 0.85% or a high-range yield of 1.05%, the filing said.

Both products will mature on Oct. 22.

Shares increased 1% in Hong Kong on Monday.

Price (HKD): $19.96, Change: $+0.20, Percent Change: +1.01%

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2453734600?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-07-22 14:59","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2453734600","market":"hk","top_or_hot":-1,"title":"Qyuns Therapeutics Subscribes to Two Wealth Management Products from Shanghai Pudong Development Bank","media":"MT Newswires Live","content":"<html><body><p> Qyuns <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a> (HKG:2509) subscribed for 160 million yuan in two wealth management products from Shanghai Pudong Development Bank (SHA:600000), according to a Friday filing with the Hong Kong Stock Exchange.</p><p>The first product is worth 100 million yuan with a guaranteed yield of 1.2% and a floating mid-range yield of 0% or 1.1% or a 1.3% high-range floating yield.</p><p>The second product is worth 60 million yuan with a guaranteed yield of 1.2% and a floating mid-range yield of 0% or 0.85% or a high-range yield of 1.05%, the filing said.</p><p>Both products will mature on Oct. 22.</p><p>Shares increased 1% in Hong Kong on Monday.</p><p>Price (HKD): $19.96, Change: $+0.20, Percent Change: +1.01%</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Qyuns Therapeutics Subscribes to Two Wealth Management Products from Shanghai Pudong Development Bank</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nQyuns Therapeutics Subscribes to Two Wealth Management Products from Shanghai Pudong Development Bank\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-07-22 14:59 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.mtnewswires.com/><strong>MT Newswires Live</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Qyuns Therapeutics (HKG:2509) subscribed for 160 million yuan in two wealth management products from Shanghai Pudong Development Bank (SHA:600000), according to a Friday filing with the Hong Kong ...</p>\n\n<a href=\"https://www.mtnewswires.com/\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02509","symbol_name":"荃信生物-B","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2453734600","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2453734600","pubTimestamp":1721631547,"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Qyuns Therapeutics  subscribed for 160 million yuan in two wealth management products from Shanghai Pudong Development Bank , according to a Friday filing with the Hong Kong Stock Exchange.The first product is worth 100 million yuan with a guaranteed yield of 1.2% and a floating mid-range yield of 0% or 1.1% or a 1.3% high-range floating yield.The second product is worth 60 million yuan with a guaranteed yield of 1.2% and a floating mid-range yield of 0% or 0.85% or a high-range yield of 1.05%, the filing said.Both products will mature on Oct. 22.Shares increased 1% in Hong Kong on Monday.Price : $19.96, Change: $+0.20, Percent Change: +1.01%","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"600000":"浦发银行","02509":"荃信生物-B","BK0188":"融资融券","BK4526":"热门中概股","BK4588":"碎股","BK0187":"一线龙头","BK0278":"货币金融","BK1161":"生物科技","BK0183":"MSCI概念","HKD":"尚乘数科","BK0012":"证金概念","LU1979443071.USD":"AB CHINA A SHARES EQUITY PORTFOLIO \"AD\" (USDHDG) INC","LU1934453819.USD":"AB CHINA A SHARES EQUITY PORTFOLIO \"A\" (USD) ACC","LENZ":"Therapeutics","BK4023":"应用软件","BK4585":"ETF&股票定投概念","BK4139":"生物科技","BK0015":"沪股通50","BK0028":"国家队","BK0201":"可转债","BK0086":"举牌"},"translate_title":"Qyuns Therapeutics认购浦发银行两只理财产品","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"600000":0.9,"HKD":1,"LENZ":1,"US3Y.BOND":0.9,"US10Y.BOND":0.9,"US12M.BOND":0.9,"US2Y.BOND":0.9,"US30Y.BOND":0.9,"US5Y.BOND":0.9,"US6M.BOND":0.9,"US7Y.BOND":0.9,"02509":0.9,"US912797HE00.BOND":0.6,"US912797GK78.BOND":0.6,"US912797GL51.BOND":0.6,"US912797GW17.BOND":0.6},"content_text":"Qyuns Therapeutics (HKG:2509) subscribed for 160 million yuan in two wealth management products from Shanghai Pudong Development Bank (SHA:600000), according to a Friday filing with the Hong Kong Stock Exchange.The first product is worth 100 million yuan with a guaranteed yield of 1.2% and a floating mid-range yield of 0% or 1.1% or a 1.3% high-range floating yield.The second product is worth 60 million yuan with a guaranteed yield of 1.2% and a floating mid-range yield of 0% or 0.85% or a high-range yield of 1.05%, the filing said.Both products will mature on Oct. 22.Shares increased 1% in Hong Kong on Monday.Price (HKD): $19.96, Change: $+0.20, Percent Change: +1.01%","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.2","shortVersion":"4.29.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2453734600"}